Lonza Group AG (LONN.SW, SIX): CHF550.20 intraday ahead of 28 Jan earnings — what to watch
LONN.SW stock trades at CHF550.20 intraday on 26 Jan 2026, down 0.90% from yesterday, as investors price in Lonza Group AG’s earnings due 28 Jan 2026 on the SIX Swiss Exchange. The company reports with trailing EPS 10.37 and a PE of 53.56, leaving valuation and free cash flow the main focus for analysts. Volume is light at 9,554 shares versus an average of 135,423, so intraday moves may amplify ahead of the print.
LONN.SW stock: Earnings preview and near-term catalysts
Lonza reports results on 28 Jan 2026, and the market will watch Biologics and Cell & Gene margins for signs of pricing or capacity pressure. The company’s segments — Biologics, Small Molecules, Cell & Gene, Capsules and Health Ingredients — drive revenue diversification and will determine guidance clarity.
Contract wins or guidance hikes could lift shares above the 50-day average CHF541.16 while weakness in contract manufacturing margins or lower FCF conversion would risk a re-rate given the PE of 53.56.
LONN.SW stock: Balance sheet, cash flow and valuation metrics
Lonza shows cash per share CHF12.92 and book value per share CHF123.62, but free cash flow per share is negative at CHF-3.80 which pressures valuation. Key ratios include PB 4.52, EV/EBITDA 24.15, and debt/equity 0.54, indicating moderate leverage against a premium multiple.
Dividend remains CHF4.00 per share with yield around 0.72%, which limits income appeal while growth expectations keep the stock at a premium.
LONN.SW stock: Meyka AI grade and model forecast
Meyka AI rates LONN.SW with a score out of 100: 68 (Grade B) — Suggestion: HOLD. This grade factors S&P 500 and sector comparison, industry metrics, financial growth, key ratios, forecasts and analyst consensus.
Meyka AI’s forecast model projects a monthly target CHF559.70 (+1.73% vs CHF550.20), a quarterly target CHF573.40 (+4.22%), and a yearly target CHF477.32 (-13.25%). Forecasts are model-based projections and not guarantees.
LONN.SW stock: Technicals and intraday trading signals
Intraday range is CHF549.20–CHF554.20 with an open at CHF553.60 and previous close CHF555.20, while RSI sits near 51.12, signalling neutral momentum. The 50-day average CHF541.16 sits below current price and the 200-day average CHF555.19 is just above, creating a tight technical band.
Volume at 9,554 is well below average which raises the risk of outsized moves when post-earnings flows arrive; Bollinger upper band is CHF556.74, suggesting immediate upside resistance near CHF556–557.
LONN.SW stock: Risks and opportunities tied to the earnings print
Opportunity: stronger Biologics throughput and Cell & Gene contract ramps could improve margins and cash flow, justifying a premium and lifting consensus price targets. Lonza’s long-term revenue per share trends are positive, supporting growth expectations.
Risk: negative free cash flow per share CHF-3.80, stretched valuation and inventory cycle (DSO 92.88 days; inventory days 141.41) could compress earnings surprises into downside moves if guidance weakens.
LONN.SW stock: Price targets and scenario analysis
We outline realistic near-term targets to frame trading around earnings: Bear CHF500.00 (-9.09%), Base CHF560.00 (+1.78%), Bull CHF620.00 (+12.68%). These targets combine valuation sensitivity and potential margin improvement from Biologics and Cell & Gene.
Analyst consensus data is limited in the feed, so traders should watch guidance language and order-book updates after the 28 Jan 2026 release before repositioning.
Final Thoughts
LONN.SW stock sits at CHF550.20 intraday on 26 Jan 2026, with market attention on the 28 Jan 2026 earnings announcement and margin commentary from Biologics and Cell & Gene operations. Valuation is stretched at a PE of 53.56 and free cash flow per share is negative CHF-3.80, which increases sensitivity to any guidance downgrade. Meyka AI’s model projects a near-term monthly target of CHF559.70 (+1.73%) and a quarterly target CHF573.40 (+4.22%), while the one-year model shows downside to CHF477.32 (-13.25%). Use these model figures as one input among guidance, order intake and margin trends. For intraday traders, watch volume and the Bollinger band ceiling near CHF556.74; for investors, focus on cash flow conversion and post-release guidance to reassess price targets. Forecasts are model-based projections and not guarantees, and Meyka AI provides these insights as an AI-powered market analysis platform.
FAQs
When does Lonza report earnings and why does it matter for LONN.SW stock
Lonza reports earnings on 28 Jan 2026 and the print matters because segment margins, guidance and cash flow conversion will drive short-term price moves and re-rate risk for LONN.SW stock.
What are the main valuation concerns for LONN.SW stock
Key concerns are a high PE of 53.56, price-to-book 4.52, and negative free cash flow per share CHF-3.80, which make the stock sensitive to earnings misses and weaker guidance.
How does Meyka AI view LONN.SW stock ahead of earnings
Meyka AI rates LONN.SW 68/100 (B, HOLD) and projects a monthly target CHF559.70 (+1.73%). The grade considers sector performance, growth and analyst inputs but is not financial advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
